Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro

A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro

A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model

Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice

A dendritic cell-based vaccine for treating HIV infection: background and preliminary results

Dendritic cell vaccine strategies for renal cell carcinoma